Hk Inno.n Corporation

This Phase 2 trial tests an experimental drug called IN-207907 in 100 elderly people with sarcopenia, a condition causing muscle loss and weakness. Participants receive three doses of the drug or a placebo by IV every four weeks. The main goal is to see if the drug improves physi…

This study tests an experimental injection called IN-B00009 in adults with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. About 110 participants will receive either the drug or a placebo to see if it safely lowers HbA1c levels over 24 weeks. …

This study tests a new injection called IN-B00009 to help adults with obesity or overweight lose weight. About 300 people will receive either the drug or a placebo for 40 weeks. The main goals are to see how much weight they lose and if the treatment is safe.

This study compares two drugs, IN-M00007 and IN-R00007, to see if they are equivalent in healthy adults aged 19 to 59. Sixty volunteers will take a single dose of each drug in random order, and researchers will measure how the drugs are absorbed and how safe they are. The goal is…

This study looks at how a new tablet called IN-M00002 behaves in the body of healthy adults aged 19 to 55. It also checks how food and other medicines (tegoprazan and naproxen) affect the drug. The goal is to gather safety and drug-level information, not to treat any disease.